Home > Qtrly Results > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Sep2026]

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹1,184 Cr ₹938 Cr ₹995 Cr ₹1,041 Cr ₹980 Cr ₹805 Cr ₹974 Cr ₹949 Cr
Expenses ₹782 Cr ₹643 Cr ₹644 Cr ₹670 Cr ₹644 Cr ₹554 Cr ₹641 Cr ₹658 Cr
Operating Income ₹402 Cr ₹296 Cr ₹351 Cr ₹371 Cr ₹336 Cr ₹251 Cr ₹333 Cr ₹292 Cr
Other Income ₹73 Cr ₹44 Cr ₹36 Cr ₹32 Cr ₹34 Cr ₹44 Cr ₹41 Cr ₹35 Cr
Interest ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹0 Cr
Depreciation ₹15 Cr ₹16 Cr ₹13 Cr ₹20 Cr ₹17 Cr ₹16 Cr ₹15 Cr ₹19 Cr
Profit Before Tax ₹459 Cr ₹322 Cr ₹373 Cr ₹400 Cr ₹354 Cr ₹279 Cr ₹359 Cr ₹308 Cr
Profit After Tax ₹336 Cr ₹237 Cr ₹278 Cr ₹296 Cr ₹257 Cr ₹205 Cr ₹263 Cr ₹230 Cr
EPS ₹19.83 ₹14.00 ₹16.40 ₹17.45 ₹15.20 ₹12.10 ₹15.52 ₹13.57
Industry Peers & Returns1W1M1Y
GLAXOSMITHKLINE PHARMACEUTICALS 0.7% -7.4% -2.6%
SUN PHARMACEUTICAL INDUSTRIES 0.7% -0.3% 3.2%
DIVIS LABORATORIES 4% 8.9% 54.1%
TORRENT PHARMACEUTICALS 3.6% -0.5% 28.8%
CIPLA 3.2% 5% -11.9%
DR REDDYS LABORATORIES 2.5% 13.6% 9.4%
MANKIND PHARMA 2.9% 2.2% 1.3%
LUPIN 0.9% 0.3% 2.8%
ZYDUS LIFESCIENCES 0.3% 4.5% 23.7%

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

26.12 %

Y-o-Y

20.78 %

Quarters Revenues % Change
Sep2026 ₹1,184 Cr
26.12
Jun2026 ₹938 Cr
-5.71
Mar2026 ₹995 Cr
-4.41
Dec2025 ₹1,041 Cr
6.26
Sep2025 ₹980 Cr
21.71
Jun2025 ₹805 Cr
-17.37
Mar2025 ₹974 Cr
2.63
Dec2024 ₹949 Cr -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

36.06 %

Y-o-Y

19.76 %

Quarters Operating Profit % Change
Sep2026 ₹402 Cr
36.06
Jun2026 ₹296 Cr
-15.80
Mar2026 ₹351 Cr
-5.50
Dec2025 ₹371 Cr
10.61
Sep2025 ₹336 Cr
33.65
Jun2025 ₹251 Cr
-24.61
Mar2025 ₹333 Cr
14.14
Dec2024 ₹292 Cr -
Operating Margins
Q-o-Q

7.88 %

Y-o-Y

-0.85 %

Quarters Operating Margin% % Change
Sep2026 33.97%
7.88
Jun2026 31.49%
-10.69
Mar2026 35.26%
-1.12
Dec2025 35.66%
4.09
Sep2025 34.26%
9.81
Jun2025 31.2%
-8.77
Mar2025 34.2%
11.22
Dec2024 30.75% -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

41.61 %

Y-o-Y

30.44 %

Quarters Profit After Tax % Change
Sep2026 ₹336 Cr
41.61
Jun2026 ₹237 Cr
-14.64
Mar2026 ₹278 Cr
-6.01
Dec2025 ₹296 Cr
14.81
Sep2025 ₹257 Cr
25.60
Jun2025 ₹205 Cr
-22.01
Mar2025 ₹263 Cr
14.35
Dec2024 ₹230 Cr -
PAT Margins
Q-o-Q

12.31 %

Y-o-Y

7.99 %

Quarters PAT Margin(%) % Change
Sep2026 28.38 %
12.31
Jun2026 25.27 %
-9.49
Mar2026 27.92 %
-1.66
Dec2025 28.39 %
8.03
Sep2025 26.28 %
3.22
Jun2025 25.46 %
-5.63
Mar2025 26.98 %
11.44
Dec2024 24.21 % -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

41.64 %

Y-o-Y

30.46 %

Quarters EPS % Change
Sep2026 ₹19.83
41.64
Jun2026 ₹14
-14.63
Mar2026 ₹16.4
-6.02
Dec2025 ₹17.45
14.80
Sep2025 ₹15.2
25.62
Jun2025 ₹12.1
-22.04
Mar2025 ₹15.52
14.37
Dec2024 ₹13.57 -

You may also like the below Video Courses